Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_00296
Species: Homo sapiens
Position : chr8:128231146-128231713
Year: 2022
Title: A stem cell marker KLF5 regulates CCAT1 via three-dimensional genome structure in colorectal cancer cells
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Normal
Disease Name: --
PMID:  34707247
MONDO:
Tissue: Pancreatic islet
Tissue Ontology ID: UBERON:0000006
Cell Source: Beta cell
CVCL ID:
Cell Type: pancreatic beta cell
Cell Ontology ID: CL:0000169
Experiment Type: Enhancer activity assay, TF binding assay, Chromatin interaction assay, Functional perturbation assay
High Throughput Method: enChIP-seq, ChIP-seq, RNA-seq
Low Throughput Method: CRISPR Knockout, ChIP-RT-qPCR, RT-RT-qPCR, Immunohistochemistry, RNA in situ Hybridization
About Target Gene
Target gene : CCAT1
About TF
TF name : KLF5
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
KLF5 Transcriptional regulation of white adipocyte differentiation reactome 79
KLF5 Hs_TGF-beta_Receptor_Signaling_WP560_90187 wikipathways 28
Enhancer Associated Network
Overlapping Enhancers (hg19) 7 found
Enhancer ID Position Tissue Cell Disease
E_00801 chr8:128210000-128260000 Breast breast carcinoma cell breast carcinoma
E_00819 chr8:128210000-128260000 Breast breast carcinoma cell breast carcinoma
E_01120 chr8:128220000-128250000 Heart cardiomyocyte --
E_01121 chr8:128220000-128250000 Blood lymphoblastoid cell --
E_00378 chr8:128230503-128380503 Colon colorectal carcinoma cell colorectal carcinoma
E_00379 chr8:128230503-128380503 Colon colorectal carcinoma cell colorectal carcinoma
E_00295 chr8:128231146-128231713 Breast breast carcinoma cell breast carcinoma
Expression of Target Genes for the Enhancer